Richard has more than 30 years continuous working experience in private practice. He has encountered a broad and varied spectrum of possible situations and scenarios involving all sorts of IP challenges and requirements.
Certain essential elements of patent work align well with Richard's character. He enjoys the sense of chase he gets in fact finding and "stone turning". This means Richard is very adept at peeling back the layers of any matter to get quickly to the heart of it, legally, technically and commercially. He also has a particularly well-honed radar for identifying risk and opportunity, and then a creative imperative and internal driver to match. Richard finds the combinations of these skills serves him well in generating excellent cost effective commercial solutions to whatever patent challenges he is presented with.
Broadly, Richard's technical knowledge and experience comes under IPC codes: A01, A21, A22, A23, A24, A61, B01, B09, B82, C02, C04, C11, C12 (C12N, C12 Q), C13, C25 and C40.
More specifically: CRISPR; gene editing; riboswitches, nucleic acid sequencing; PCR based assays; nucleic acid-based diagnostics; antibodies (therapeutic or diagnostic), immunoaffinity purification; chimeric T cells and therapies; miRNA, siRNA, oncology; biomarkers; bioinformatics; enzymes; epigenetics; modified bacteria, viruses, algae, fungi, plants, insects (mosquitoes), fish and fish feed, animals, plant secondary compounds; oligosaccharides; pest control; plant breeding tools; plant protection products; biodegradable packaging; sewage treatments; human pharmaceutical formulations (small molecules, proteins, antibodies); vaccines (anticancer, influenza); medical devices; ocular devices, diagnostics and therapies.
Natural Science (Oxon)
Patent Litigation (Nottingham Trent)
Plant Science (Wales)
“…excellent knowledge, experience and analytical acumen…”. (Legal 500 - 2011) “…superb…”’ (Legal 500 - 2012)
November 28th 2019
November 28th 2019
June 3rd 2019
9th Microbiome R&D and Business Collaboration Forum: Europe will be held on 26th-27th October 2021 in Rotterdam, The Netherlands. The event is dedicated to exploring microbiome research and strategies for …Event details
Medical Technology Ireland Conference will be held on 20-21 October 2021 at the Galway Racecourse. Medical Technology Ireland Conference features presentations by leading international medical device experts with thought-provoking guest …Event details
HGF and Knobbe Martens are holding a webinar on 3rd November. Challenging granted patents: a comparison between Europe and the US In this webinar we will compare and contrast mechanisms …Event details
HGF’s Attorney-At-Law Olivia Petter will be speaking at the WIPR Patents Live Broadcast on Tuesday 26th October. WIPR Patents Live is a programme that gives you access to unmissable live …Event details
IPBC Europe: Leadership Summit will be held in-person on 4-5 October in Dublin. The conference is the top European gathering of senior corporate IP professionals. It will be covering the …Event details
HGF is sponsoring The Business of Science Conference 2021 on 7th October. Science and the commercialisation of science continues to be fundamental to the economic growth of the UK and …Event details
IAM Strategy 300 Global Leaders guide has been published and HGF is delighted to have 4 Partners listed. The guide draws from the worlds of private practice, consulting and other …Read article
HGF’s Partner Dr Markus Zoller is attending and speaking at the German Biotechnology days on 20th September 2021. German Biotechnology days is the go to event in the industry and …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.